Related Experiment Video
Updated: Apr 5, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Drugging the Ral GTPase
Chao Yan1, David N M Jones, Dan Theodorescu
1a Departments of Surgery (Urology) and Pharmacology ; University of Colorado ; Aurora , CO USA.
Abstract:
The RAL GTPases have emerged as important drivers of tumor growth and metastasis in lung, colon, pancreatic and other cancers. We recently developed the first small molecule inhibitors of RAL that exhibited antitumor activity in human lung cancer cell lines. These compounds are non-competitive inhibitors that bind to the allosteric site of GDP-bound RAL. The RAL inhibitors have the potential to be used in combination therapy with other inhibitors of the RAS signaling pathway. They also provide insights toward directly targeting other GTPases.
Insights
Small molecule inhibitors targeting RAL GTPases show promise in fighting lung cancer. These novel compounds, which block tumor growth and metastasis, offer new therapeutic strategies for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- RAL GTPases are key regulators of cell growth and are implicated in various cancers.
- Dysregulation of RAL GTPases contributes to tumor progression and metastasis.
Purpose of the Study:
- To develop and characterize novel small molecule inhibitors of RAL GTPases.
- To evaluate the antitumor activity of these inhibitors in human lung cancer models.
Main Methods:
- Development of allosteric, non-competitive inhibitors targeting GDP-bound RAL.
- In vitro testing of inhibitor efficacy against human lung cancer cell lines.
Main Results:
- Successfully developed the first small molecule inhibitors of RAL with demonstrated antitumor activity.
- Inhibitors bind to an allosteric site on GDP-bound RAL, blocking its function.
Conclusions:
- RAL GTPase inhibitors represent a promising new therapeutic avenue for lung cancer.
- These inhibitors may be effective in combination therapies targeting the RAS signaling pathway.
- The findings provide a basis for targeting other GTPases.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation
Activation and Inactivation of G Proteins
Rab Cascades
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...

